Degrader discovery and design at TPD Summit 2026
Oct 26–29, 2026 Boston, MA ~300 attendees Website
45 organizations at TPD Summit 2026 present work in degrader discovery & design: 22 drug developers, 13 technology and service providers and 10 academic, government and non-profit bodies. Between them they bring 57 presentations to the program. Most represented: Protai (2 on the program), Astellas (2 on the program), AstraZeneca (2 on the program). As of Oct 20, 2026.
Format
Top represented
Showing 1–14 of 45 organizations
| Organization | TPD Summit 2026 Attendance |
|---|---|
Combines proteomics and AI to discover drug targets, biomarkers and degraders. | Panel Tue Oct 27 3:10pm Talk Wed Oct 28 11:30am Proteomics & AI Platform Maps Degrader-Induced Ternary Complex Diversity to Enable Rational Degrader Design AI & computational designScreening, assays & proteomics Panel Thu Oct 29 10:00am |
Astellas Tokyo, Japan | ◇Industry Partner |
Japanese pharmaceutical company with a targeted protein degradation program, including the KRAS G12D degrader setidegrasib. | Talk Tue Oct 27 2:00pm Talk Wed Oct 28 3:00pm |
AstraZeneca Cambridge, UK | |
Global pharmaceutical company developing medicines in oncology, cardiovascular, renal, respiratory, immunology and rare diseases. | Talk Wed Oct 28 2:30pm Linking Molecular Glue Binding Kinetics to Functional Performance Through Quantitative Modeling AI & computational design Talk Thu Oct 29 9:30am Developing AURKB PROTACs as a Novel Payload Class for Next-Generation Degrader Antibody Conjugates (DACs) Degrader conjugates & tissue targeting |
Foghorn Therapeutics Cambridge, MA | |
Clinical-stage biotech targeting the chromatin regulatory system with small molecules and protein degraders for cancer. | Panel Tue Oct 27 9:00am Navigating the Evolving Induced Proximity Landscape: Trends, Opportunities & Global Impact Investment, partnering & strategy Talk Thu Oct 29 10:30am Proximity by Design: Harnessing Induced Proximity for Challenging Targets Degrader discovery & design |
Yale University New Haven, CT | |
Private research university in New Haven, Connecticut, with a school of medicine. | Talk Mon Oct 26 1:45pm Enhancing Inhibition via Chemically Induced Proximity: A RIPTAC Targeting BCL6 & BET Proteins Induced proximity beyond degradation Panel Mon Oct 26 2:15pm |
Develops cancer therapeutics built on p27 biology, including molecular glue stabilizers, for drug-resistant cancers. | Panel Tue Oct 27 3:10pm Talk Thu Oct 29 12:15pm Locktacs for Intrinsically Disordered Proteins: First-in-Class p27 Molecular Glue Stabilizers Induced proximity beyond degradation |
Drug discovery consultancy advising biotech management teams and investors. | Chair Mon Oct 26 8:50am Chair’s Opening Remarks Degrader discovery & design Panel Mon Oct 26 2:15pm Chair Mon Oct 26 4:15pm Chair’s Closing Remarks Screening, assays & proteomics |
Albert Einstein College of Medicine Bronx, NY | |
Medical school and biomedical research institution in the Bronx, New York. | Talk Mon Oct 26 9:30am αC-Helix–Proximal Allostery as a Platform for Selective Kinase Modulation & Complex Degradation Degrader discovery & designInduced proximity beyond degradation Panel Mon Oct 26 2:15pm |
Broad Institute Cambridge, MA | |
Biomedical and genomic research institute in Cambridge, Massachusetts, founded by MIT and Harvard. | Panel Mon Oct 26 2:15pm Talk Mon Oct 26 3:45pm Diverse Mechanisms of Small Molecule Induced Protein Degradation Degrader discovery & design |
Indiana biotech discovering small-molecule degraders of proteins that cause neurodegenerative disease, starting from an APP degrader. | Talk Wed Oct 28 4:15pm Molecular Glue Degrader–Induced Co-Degradation of Mutant KRAS & CRAF Drives In Vivo Responses Degrader discovery & design Talk Thu Oct 29 2:15pm |
Georgia Institute of Technology Atlanta, GA | |
Public research university in Atlanta, Georgia. | Talk Mon Oct 26 3:15pm GlueFinder: A Data-Driven Framework for the Rational Discovery of Molecular Glues AI & computational designDegrader discovery & design Panel Tue Oct 27 3:10pm |
Biotech developing targeted protein degraders. | Chair Thu Oct 29 8:20am Chair’s Opening Remarks Degrader conjugates & tissue targeting Chair Thu Oct 29 2:45pm Chair’s Closing Remarks Degrader discovery & design |
Develops targeted protein degraders that use a new E3 ligase, aiming to reduce hematologic toxicity. | Talk Tue Oct 27 12:30pm |
UC Irvine Irvine, CA | |
Public research university in Irvine, California. | Talk Mon Oct 26 10:00am Methylarginine Targeting Chimeras for Lysosomal Degradation of Intracellular Proteins Degrader discovery & design Panel Mon Oct 26 2:15pm |
Instantly find 20 buyers in degrader discovery & design
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse TPD Summit 2026 by
Organization type
Topic
Everyone
Not affiliated with or endorsed by the TPD & Induced Proximity Summit or its organizers. Submit a correction